• 1
    Kurihara N, Chenu C, Miller M, Civin C, Roodman GD 1990 Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term human marrow cultures. Endocrinology 126:27332741.
  • 2
    Roodman GD 2001 Biology of osteoclast activation in cancer. J Clin Oncol 19:35623571.
  • 3
    Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T 1990 Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:72607264.
  • 4
    Biskobing DM, Rubin J 1993 1, 25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line. Endocrinology 132:862866.
  • 5
    Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:13731382.
  • 6
    Elias JA, Tang W, Horowitz MC 1995 Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136:489498.
  • 7
    Hentunen TA, Reddy SV, Boyce BF, Devlin R, Park HR, Chung H, Selander KS, Dallas M, Kurihara N, Galson DL, Goldring SR, Koop BA, Windle JJ, Roodman GD 1998 Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest 102:8897.
  • 8
    Choi SJ, Han JH, Roodman GD 2001 ADAM 8: A novel osteoclastic stimulating factor. J Bone Miner Res 16:814822.
  • 9
    Owhashi M, Arita H, Hayai N 2000 Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J Biol Chem 275:12791286.
  • 10
    Schall TJ, Bacon K, Toy KJ, Goeddel DV 1990 Selective attraction of monocytes and T lymphocytes of the memory phenotype by the cytokine RANTES. Nature 347:669671.
  • 11
    Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ 1989 Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:14851490.
  • 12
    Rollins BJ, Walz A, Baggiolini M 1991 Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:11121116.
  • 13
    Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ 1993 Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260:355358.
  • 14
    Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA 1992 RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176:14891495.
  • 15
    Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M 2000 Macrophage inflammatory protein-1α is a potential osteoclast stimulatory factor in myeloma. Blood 996:671675.
  • 16
    Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD 2001 Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kB ligand. Blood 97:33493353.
  • 17
    Hentunen TA, Jackson SH, Chung H, Reddy SV, Lorenzo J, Choi SJ, Roodman GD 1999 Characterization of immortalized osteoclast precursors developed from mice transgenic for both Bcl-XL and Simian virus 40 large T antigen. Endocrinology 140:29542961.
  • 18
    Choi SJ, Reddy SV, Devlin RD, Menaa C, Chung H, Boyce BF, Roodman GD 1999 Identification of human asparaginyl endopeptidase (legumain) as autocrine inhibitor of osteoclast formation and bone resorption. J Biol Chem 274:2774727753.
  • 19
    Yates AJ, Oreffo RO, Mayer K, Mundy GR 1991 Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J Bone Miner Res 6:473478.
  • 20
    Horton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ 1985 Monoclonal antibodies to osteoclastomas (giant cell bone tumors): Definition of an osteoclast-specific cellular antigen. Cancer Res 45:56635669.
  • 21
    Nomura S, Hirakawa K, Nagoshi J, Hirota S, Kim HM, Takemura T, Nakase T, Takaoka K, Matsumoto S, Nakajima Y, Takebashi K, Takano-Yamamoto T, Ikeda T, Kitamura Y 1993 Method for detecting the expression of bone matrix protein by in situ hybridization using decalcified mineralized tissue. Acta Histochem Cytochem 26:303309.
  • 22
    Choi SJ, Devlin RD, Menaa C, Chung H, Roodman GD, Reddy SV 1998 Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. J Clin Invest 102:13601368.
  • 23
    Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt-Lindqvist S, Takahashi M, Matsuda F, Yaoita Y, Takatsu K, Honjo T 1986 Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324:7073.
  • 24
    Schall TJ, Simpson NJ, Mak JY 1992 Molecular cloning and expression of the murine RANTES cytokine: Structural and functional conservation between mouse and man. Eur J Immunol 22:14771481.
  • 25
    Rothenberg ME, Luster AD, Leder P 1995 Murin eotaxin: An eosinophil chemoattractant inducible in endothelial cells and interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92:89608964.
  • 26
    Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M 1998 Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273:1697616984.
  • 27
    Baggiolini M, Dewald B, Moser B 1997 Human chemokines: An update. Annu Rev Immunol 15:675705.
  • 28
    Kunkel SL 1999 Through the looking glass: The diverse in vivo activities of chemokines. J Clin Invest 104:13331334.
  • 29
    Votta BJ, White JR, Dodds RA, James IE, Conner JR, Lee-Rykaczweski E, Eichman CF, Kumar S, Lark MW, Gowen M 2000 CKβ-8(CCL23), a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissue. J Cell Phys 183:196207.
  • 30
    Forssmann U, Delgado MB, Uguccioni M, Loestcher P, Garrotta G, Bagiolini M 1997 CKβ-8, a novel cc chemokine that predominately acts on monocytes. FEBS Lett 408:211216.
  • 31
    Macphee CH, Appelbaum ER, Johanson K, Moores KE, Imburgia CS, Fornwald J, Berkhout T, Brawner M, Groot PH, O'Donnell K, O'Shannessy D, Scott G, White JR 1998 Identification of a truncated from of the CC chemokine CKβ-8 demonstrating greatly enhanced biological activity. J Immunol 161:62736279.